PURE Bioscience (OTCMKTS: PURE) and Ashland Global Holdings (NYSE:ASH) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk.

Volatility and Risk

PURE Bioscience has a beta of -1.41, suggesting that its stock price is 241% less volatile than the S&P 500. Comparatively, Ashland Global Holdings has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500.


This table compares PURE Bioscience and Ashland Global Holdings’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
PURE Bioscience -276.96% -125.22% -74.90%
Ashland Global Holdings -4.71% 10.62% 3.70%


Ashland Global Holdings pays an annual dividend of $0.90 per share and has a dividend yield of 1.4%. PURE Bioscience does not pay a dividend. Ashland Global Holdings pays out -25.4% of its earnings in the form of a dividend. PURE Bioscience has raised its dividend for 7 consecutive years.

Analyst Recommendations

This is a summary of recent ratings and price targets for PURE Bioscience and Ashland Global Holdings, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PURE Bioscience 0 0 0 0 N/A
Ashland Global Holdings 0 2 2 0 2.50

Ashland Global Holdings has a consensus price target of $83.50, indicating a potential upside of 26.23%. Given Ashland Global Holdings’ higher probable upside, analysts plainly believe Ashland Global Holdings is more favorable than PURE Bioscience.

Institutional & Insider Ownership

0.3% of PURE Bioscience shares are owned by institutional investors. Comparatively, 92.5% of Ashland Global Holdings shares are owned by institutional investors. 16.4% of PURE Bioscience shares are owned by company insiders. Comparatively, 1.3% of Ashland Global Holdings shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares PURE Bioscience and Ashland Global Holdings’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
PURE Bioscience $1.84 million 35.23 -$5.72 million ($0.08) -12.88
Ashland Global Holdings $5.06 billion 0.82 $719.00 million ($3.54) -18.69

Ashland Global Holdings has higher revenue and earnings than PURE Bioscience. Ashland Global Holdings is trading at a lower price-to-earnings ratio than PURE Bioscience, indicating that it is currently the more affordable of the two stocks.


Ashland Global Holdings beats PURE Bioscience on 11 of the 15 factors compared between the two stocks.

About PURE Bioscience

PURE Bioscience, Inc. is focused on developing and commercializing antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. The Company’s technology platform is based on stabilized ionic silver and its products contain silver dihydrogen citrate (SDC). It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains and food processors. It is testing and continuing development of PURE Control to utilize PURE Control as a direct food contact processing aid for raw meats, including beef and pork. In addition to PURE Hard Surface and PURE Control, it manufactures and sells SDC-based products for end use; products preserved with SDC, and SDC as a raw material ingredient for manufacturing use. These products include PURE Multi-Purpose and Floor Cleaner Concentrate, PURE Multi-Purpose Hi-Foam Cleaner Concentrate, Axen 30, Axenohl and SILVERION.

About Ashland Global Holdings

Ashland Inc. is engaged in specialty chemicals, and through Valvoline, is a consumer-branded lubricant supplier. The Company operates in three segments: Ashland Specialty Ingredients (Specialty Ingredients), Ashland Performance Materials (Performance Materials) and Valvoline. Its Specialty Ingredients segment is engaged in providing cellulose ethers, vinyl pyrrolidones and biofunctionals, and consists of two divisions: Consumer Specialties and Industrial Specialties. Its Performance Materials segment is engaged in providing unsaturated polyester resins and vinyl ester resins, and consists of two divisions: Composites and Intermediates/Solvents. Its Valvoline segment is engaged in producing and distributing automotive, commercial and industrial lubricants, and automotive chemicals. Its chemistry is used in various markets and applications, including architectural coatings, adhesives, automotive, construction, energy and pharmaceutical.

Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.